Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.

Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK, Shaw PJ, Haight AE, Grimley M, Grupp SA, Kletzel M, Kadota R
Blood. 2009 114 (7): 1429-36

PMID: 19528536 · DOI:10.1182/blood-2009-01-196303

MeSH Terms (19)

Adolescent Adult Bone Marrow Transplantation Child Child, Preschool Disease-Free Survival Female Hematologic Neoplasms Humans Infant Male Myeloablative Agonists Peripheral Blood Stem Cell Transplantation Recurrence Survival Rate Time Factors Transplantation, Homologous Transplantation Conditioning Whole-Body Irradiation

Connections (1)

This publication is referenced by other Labnodes entities: